0001437749-23-018282.txt : 20230623 0001437749-23-018282.hdr.sgml : 20230623 20230623164634 ACCESSION NUMBER: 0001437749-23-018282 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230621 FILED AS OF DATE: 20230623 DATE AS OF CHANGE: 20230623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kiener Peter A CENTRAL INDEX KEY: 0001328146 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37471 FILM NUMBER: 231038382 MAIL ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PIERIS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001583648 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 300784346 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 225 FRANKLIN STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-246-8998 MAIL ADDRESS: STREET 1: 225 FRANKLIN STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 FORMER COMPANY: FORMER CONFORMED NAME: Marika Inc. DATE OF NAME CHANGE: 20130805 4 1 rdgdoc.xml FORM 4 X0407 4 2023-06-21 0001583648 PIERIS PHARMACEUTICALS, INC. PIRS 0001328146 Kiener Peter A C/O PIERIS PHARMACEUTICALS, INC. 225 FRANKLIN STREET, 26TH FLOOR BOSTON MA 02110 1 0 Stock Option (right to buy) 0.26 2023-06-21 4 A 0 40000 0 A 2033-06-21 Common Stock 40000 40000 D The stock option will vest as to 100% of the underlying shares on the date of the Company's 2024 annual stockholders meeting, subject to the Reporting Person's continued service as a director through the vesting date. /s/ Ahmed Mousa, Attorney-in-Fact 2023-06-23